# Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer

> **NCT00217724** · NA · TERMINATED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 18 (actual)

## Conditions studied

- Pain
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DIETARY_SUPPLEMENT:** glutamine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00217724
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-07
- **Primary completion:** 2009-01
- **Final completion:** 2009-03
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Only able to accrue just 18 of the 40 target \& funds were limited.
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00217724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00217724, "Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00217724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*